CLDN19
Basic information
Region (hg38): 1:42733093-42740254
Links
Phenotypes
GenCC
Source:
- renal hypomagnesemia 5 with ocular involvement (Definitive), mode of inheritance: AR
- renal hypomagnesemia 5 with ocular involvement (Strong), mode of inheritance: AR
- renal hypomagnesemia 5 with ocular involvement (Strong), mode of inheritance: AR
- renal hypomagnesemia 5 with ocular involvement (Strong), mode of inheritance: AR
- renal hypomagnesemia 5 with ocular involvement (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Hypomagnesemia 5, renal, with or without ocular involvement | AR | Renal | Electrolyte replacement and surveillance for sequelae such as urinary tract infections can be beneficial | Ophthalmologic; Renal | 500385; 7947033; 17033971; 21030577; 21791920; 22422540; 23301036; 23538362 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (84 variants)
- Renal_hypomagnesemia_5_with_ocular_involvement (71 variants)
- Inborn_genetic_diseases (35 variants)
- CLDN19-related_disorder (7 variants)
- Nephrocalcinosis (1 variants)
- Renal_Hypomagnesemia,_Recessive (1 variants)
- not_specified (1 variants)
- Nephrolithiasis (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CLDN19 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000148960.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 26 | 27 | ||||
| missense | 11 | 62 | 82 | |||
| nonsense | 5 | |||||
| start loss | 0 | |||||
| frameshift | 5 | |||||
| splice donor/acceptor (+/-2bp) | 4 | |||||
| Total | 9 | 17 | 66 | 30 | 1 |
Highest pathogenic variant AF is 0.000023451801
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CLDN19 | protein_coding | protein_coding | ENST00000296387 | 5 | 7162 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00497 | 0.895 | 125695 | 0 | 5 | 125700 | 0.0000199 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.779 | 112 | 138 | 0.813 | 0.00000866 | 1389 |
| Missense in Polyphen | 44 | 58.186 | 0.75619 | 590 | ||
| Synonymous | 1.46 | 49 | 63.8 | 0.768 | 0.00000461 | 497 |
| Loss of Function | 1.40 | 5 | 9.71 | 0.515 | 4.17e-7 | 108 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00 | 0.00 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.0000950 | 0.0000924 |
| European (Non-Finnish) | 0.0000179 | 0.0000176 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000327 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium- independent cell-adhesion activity. {ECO:0000250|UniProtKB:Q9ET38}.;
- Disease
- DISEASE: Hypomagnesemia 5, renal, with or without ocular involvement (HOMG5) [MIM:248190]: A progressive renal disease characterized by primary renal magnesium wasting with hypomagnesemia, hypercalciuria and nephrocalcinosis associated with severe ocular abnormalities such as bilateral chorioretinal scars, macular colobomata, significant myopia and nystagmus. The renal phenotype is virtually undistinguishable from that of patients with HOMG3. {ECO:0000269|PubMed:17033971}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Cell adhesion molecules (CAMs) - Homo sapiens (human);Tight junction - Homo sapiens (human);Hepatitis C - Homo sapiens (human);Leukocyte transendothelial migration - Homo sapiens (human);EMT transition in Colorectal Cancer;Tight junction interactions;Cell-cell junction organization;Cell junction organization;Cell-Cell communication
(Consensus)
Recessive Scores
- pRec
- 0.142
Intolerance Scores
- loftool
- 0.0854
- rvis_EVS
- 0.68
- rvis_percentile_EVS
- 84.93
Haploinsufficiency Scores
- pHI
- 0.177
- hipred
- N
- hipred_score
- 0.444
- ghis
- 0.496
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.269
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cldn19
- Phenotype
- homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);
Gene ontology
- Biological process
- visual perception;calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules;neuronal action potential propagation;apical junction assembly;response to stimulus
- Cellular component
- nucleus;cytoplasm;bicellular tight junction;integral component of membrane;basolateral plasma membrane;apical junction complex
- Molecular function
- structural molecule activity;identical protein binding